[144] Agilent Technologies Inc. SEC Filing

Rhea-AI Filing Summary

Agilent Technologies Inc. (symbol: A) has filed a Form 144, signaling the intention to sell 1,508 shares of its common stock, valued at roughly $177,099.52. The shares, originally received through restricted-stock vesting on 11/14/2023, are planned to be sold on or around 07/01/2025 via Fidelity Brokerage Services LLC on the NYSE. With 284,064,728 shares outstanding, the proposed sale represents less than 0.001% of total shares, indicating a de-minimis effect on the company’s share structure. The filer reported no other sales in the past three months and certified that no undisclosed material adverse information is known.

Insights

Securities Analyst

TL;DR: Small insider sale (1,508 shares) is statistically immaterial; neutral for valuation and liquidity.

The Form 144 covers a routine disposition of shares gained from restricted-stock vesting. At a value of roughly $177k against a market capitalization in the tens of billions, the transaction does not alter float, insider ownership, or governance dynamics. Absence of other recent sales and the standard certification language further support a neutral investor impact. Overall, the filing is administrative rather than strategic.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1508	177099.52	284064728	07/01/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/14/2023	Restricted Stock Vesting	Issuer			1508	11/14/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Agilent Technologies' Form 144 filing disclose?

It discloses a planned sale of 1,508 common shares valued at about $177,099.52.

When are the Agilent (A) shares expected to be sold?

The approximate sale date listed is 07/01/2025.

How were the shares being sold originally acquired?

They vested as restricted stock on 11/14/2023 and were received as compensation from the issuer.

What percentage of Agilent's outstanding shares does the proposed sale represent?

Less than 0.001% of the 284,064,728 shares outstanding.

Does the Form 144 indicate any other recent insider sales?

No. The section “Securities Sold During the Past 3 Months” shows “Nothing to Report.”